Home » Topics » BioWorld Science

BioWorld Science
RSS

Zimycan receives approval in Belgium for treatment of diaper dermatitis

May 25, 2004

Avelox approved for treatment of CAP caused by multidrug resistant S. pneumoniae

May 25, 2004

MorphoSys and Novartis to discover and develop antibody-based therapeutic agents

May 25, 2004

FDA approves Taxotere for treatment of prostate cancer

May 25, 2004

Favrille receives SPA from FDA for FavID

May 25, 2004

Biomira and Inno-centre Alberta to create spin-off company to develop L-IL-2 technology

May 25, 2004

ProMetic achieves second milestone in AM-Pharma agreement

May 25, 2004

Enrollment completed in phase III trial of enoximone

May 25, 2004

Alemtuzumab use may reduce tacrolimus toxicity in liver transplantation

May 25, 2004

Valganciclovir simple, effective as CMV prophylaxis in renal transplantation

May 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...